The Vasohibin Family.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27713261)

Published in Pharmaceuticals (Basel) on February 05, 2010

Authors

Yasufumi Sato1

Author Affiliations

1: Department of Vascular Biology, Institute of Development, Aging and Cancer, Tohoku University, 4-1 Seiryo-machi, Aoba-ku, Sendai 980-8575, Japan. y-sato@idac.tohoku.ac.jp.

Articles cited by this

Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res (2003) 4.39

Angiogenesis: a team effort coordinated by notch. Dev Cell (2009) 4.05

Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest (2004) 1.90

Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res (2007) 1.48

Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis. Blood (2009) 1.47

Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization. FASEB J (2006) 1.35

Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene (2002) 1.27

Vasohibin-1 expression in endothelium of tumor blood vessels regulates angiogenesis. Am J Pathol (2009) 1.24

cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis (2001) 1.15

Isolation and characterization of vasohibin-2 as a homologue of VEGF-inducible endothelium-derived angiogenesis inhibitor vasohibin. Arterioscler Thromb Vasc Biol (2006) 1.11

Gene regulation of a novel angiogenesis inhibitor, vasohibin, in endothelial cells. Biochem Biophys Res Commun (2005) 1.08

Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis. Am J Pathol (2010) 1.06

Vasohibin prevents arterial neointimal formation through angiogenesis inhibition. Biochem Biophys Res Commun (2006) 1.05

Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer. Cancer Sci (2008) 1.04

Endostatin inhibits lymph node metastasis by a down-regulation of the vascular endothelial growth factor C expression in tumor cells. Clin Exp Metastasis (2005) 1.03

Vasohibin-1 in human breast carcinoma: a potential negative feedback regulator of angiogenesis. Cancer Sci (2008) 0.99

Update on endogenous inhibitors of angiogenesis. Endothelium (2006) 0.99

Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation. Arterioscler Thromb Vasc Biol (2008) 0.98

Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo. BMC Cancer (2009) 0.95

Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Diabetologia (2008) 0.90

Analysis of Schistosoma mansoni genes shared with Deuterostomia and with possible roles in host interactions. BMC Genomics (2007) 0.87

Recombinant adenovirus encoding vasohibin prevents tumor angiogenesis and inhibits tumor growth. Cancer Sci (2009) 0.86

Inflammatory cytokine-induced expression of vasohibin-1 by rheumatoid synovial fibroblasts. Acta Med Okayama (2009) 0.85

Expression pattern of Vasohibin during chick development. Dev Dyn (2007) 0.84

Expression of vasohibin, an antiangiogenic factor, in human choroidal neovascular membranes. Am J Ophthalmol (2008) 0.84

Multiple processing forms and their biological activities of a novel angiogenesis inhibitor vasohibin. Biochem Biophys Res Commun (2006) 0.83

Induction and expression of anti-angiogenic vasohibins in the hematopoietic stem/progenitor cell population. J Biochem (2009) 0.83